Will taking osimertinib cause tumors to grow?

Osimertinib is a targeted therapy for lung cancer, especially for patients with non-small cell lung cancer with EGFR gene mutations. It controls the disease by inhibiting the growth and spread of tumor cells. However, tumor response varies from person to person. Some patients may respond well to osimertinib, with tumors shrinking or remaining stable, while others may experience tumor enlargement.

Tumor growth was not necessarily caused entirely by osimertinib. Tumors themselves are heterogeneous, that is, tumor cells in different locations may have different properties and behaviors. This means that different tumor cells in the same patient may respond differently to the drug. Some tumor cells may be sensitive to osimertinib, while others may be insensitive or resistant. Therefore, some tumor lesions may increase even while taking osimertinib.

The patient's own physical condition, genetic variation and other treatment factors may also affect the efficacy of osimertinib. For example, certain genetic mutations may cause tumor cells to become less sensitive to drugs, thereby affecting their efficacy. At the same time, if the patient fails to follow the doctor's instructions while taking the medicine, such as not taking the medicine on time or underdosing, etc., the efficacy of the medicine may also be affected.

It should be emphasized that if patients experience tumor growth while taking osimertinib, they should seek medical advice promptly and seek professional advice. Doctors will evaluate and adjust treatment plans based on the patient's specific situation to best control the progression of the disease.